These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 8909848

  • 1. Antibody responses to two Epstein-Barr virus (EBV) nuclear antigens (EBNA-1 and EBNA-2) during EBV primary infection in children born to mothers infected with human immunodeficiency virus.
    Pedneault L, Lapointe N, Alfieri C, Ghadirian P, Carpentier L, Samson J, Joncas J.
    Clin Infect Dis; 1996 Oct; 23(4):806-8. PubMed ID: 8909848
    [Abstract] [Full Text] [Related]

  • 2. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients.
    Riddler SA, Breinig MC, McKnight JL.
    Blood; 1994 Aug 01; 84(3):972-84. PubMed ID: 8043879
    [Abstract] [Full Text] [Related]

  • 3. Maintenance of serum immunoglobulin G antibodies to Epstein-Barr virus (EBV) nuclear antigen 2 in healthy individuals from different age groups in a Japanese population with a high childhood incidence of asymptomatic primary EBV infection.
    Harada S, Kamata Y, Ishii Y, Eda H, Kitamura R, Obayashi M, Ito S, Ban F, Kuranari J, Nakajima H, Kuze T, Hayashi M, Okabe N, Senpuku H, Miyasaka N, Nakamura Y, Kanegane H, Yanagi K.
    Clin Diagn Lab Immunol; 2004 Jan 01; 11(1):123-30. PubMed ID: 14715558
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Synthetic peptides deduced from the amino acid sequence of Epstein-Barr virus nuclear antigen 6 (EBNA 6): antigenic properties, production of monoreactive reagents, and analysis of antibody responses in man.
    Falk K, Linde A, Johnson D, Lennette E, Ernberg I, Lundkvist A.
    J Med Virol; 1995 Aug 01; 46(4):349-57. PubMed ID: 7595412
    [Abstract] [Full Text] [Related]

  • 7. Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1.
    Jenson H, McIntosh K, Pitt J, Husak S, Tan M, Bryson Y, Easley K, Shearer W.
    J Infect Dis; 1999 Jun 01; 179(6):1395-404. PubMed ID: 10228060
    [Abstract] [Full Text] [Related]

  • 8. Natural history of Epstein-Barr virus infection in a prospective pediatric cohort born to human immunodeficiency virus-infected mothers.
    Pedneault L, Lapointe N, Alfieri C, Ghadirian P, Carpentier L, Samson J, Joncas J.
    J Infect Dis; 1998 Apr 01; 177(4):1087-90. PubMed ID: 9534989
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
    Marchini B, Dolcher MP, Sabbatini A, Klein G, Migliorini P.
    J Autoimmun; 1994 Apr 01; 7(2):179-91. PubMed ID: 7518683
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum responses to the combination of Epstein-Barr virus antigens from both latent and acute phases in nasopharyngeal carcinoma: complementary test of EBNA-1 with EA-D.
    Chow KC, Ma J, Lin LS, Chi KH, Yen SH, Liu SM, Liu WT, Chen WK, Chang TH, Chen KY.
    Cancer Epidemiol Biomarkers Prev; 1997 May 01; 6(5):363-8. PubMed ID: 9149897
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE, Peng R, Cole KS, Montelaro RC, Sturgeon T, Jenson HB, Ling PD.
    J Med Virol; 2002 Jul 01; 67(3):320-6. PubMed ID: 12116021
    [Abstract] [Full Text] [Related]

  • 18. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S, Feghoul L, Salmona M, Herda A, Mercier-Delarue S, Simon F, Legoff J.
    J Med Virol; 2017 Nov 01; 89(11):2003-2010. PubMed ID: 28661055
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP.
    Oral Oncol; 2008 Aug 01; 44(8):784-92. PubMed ID: 18206420
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.